Development of the Migraine‐Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study
This population-based study of >60,000 people with migraine allowed the development and validation of the first migraine-specific measure of perceived external stigma for people with migraine. This study demonstrated that MiRS consists of two internally consistent subscales: Secondary Gain and Minimizing Burden. This may be a useful tool for quantifying perceived migraine-related stigma to understand determinants of migraine-related stigma and test interventions to reduce perceived migraine-related stigma.
Authors
- Richard B. Lipton (ORCID: https://orcid.org/0000-0003-2652-2897)
- Elizabeth K. Seng (ORCID: https://orcid.org/0000-0002-8938-4949)
- Anthony J. Zagar (ORCID: https://orcid.org/0000-0002-8353-6665)
- Dawn C. Buse (ORCID: https://orcid.org/0000-0002-3784-6144)
- Susan Hutchinson (ORCID: https://orcid.org/0000-0001-6353-2846)
- Michael L. Reed (ORCID: https://orcid.org/0000-0002-1353-2300)
- Sait Ashina (ORCID: https://orcid.org/0000-0003-3973-6640)
- E. Jolanda Muenzel (ORCID: https://orcid.org/0009-0000-7929-3704)
- Robert A. Nicholson (ORCID: https://orcid.org/0000-0002-2725-9739)
- Robert E. Shapiro (ORCID: https://orcid.org/0000-0002-7401-0514)
Institutions
- University of Vermont (US)
- Albert Einstein College of Medicine (US)
- Beth Israel Deaconess Medical Center (US)
- Montefiore Medical Center (US)
- Harvard University (US)
- Eli Lilly (United States) (US)
- Yeshiva University (US)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1111/head.14886
- Citations
- 4
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.88
Funders
- Eli Lilly and Company